Clinical trials
3 active studies led by Afasci Inc, of 4 in all
Source: ClinicalTrials.gov, Studies with Afasci Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 2Markets in public records
- 0Regions & countries
- 3Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Afasci Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Afasci Inc
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Afasci Inc leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Afasci Inc or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Afasci Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Afasci Inc is in.
From our blog
Stories on the topics Afasci Inc works in.
Adaptogens: Ancient Herbs, Modern Market
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Stress and Mood Supplements: Ashwagandha and Beyond
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
Antidepressants: Demand, Access and New Approaches
About 322 million people live with depression. Treatment works, but most people still do not get it.
Read